pargyline has been researched along with Sleep Wake Disorders in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Sleep Wake Disorders: Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadlecová, O | 1 |
| Masek, K | 1 |
| Rasková, H | 1 |
| Rotta, J | 1 |
1 other study available for pargyline and Sleep Wake Disorders
| Article | Year |
|---|---|
Fever and sleep cycle impairment after streptococcal mucopeptide administration.
Topics: Animals; Body Temperature; Electroencephalography; Fever; Humans; Male; Pargyline; Peptides; Pyrogen | 1972 |